Pasithea Therapeutics Stock (NASDAQ: KTTA) stock price, news, charts, stock research, profile.
You can purchase shares of Pasithea Therapeutics (NASDAQ:KTTA) through any online brokerage.
There are no as such competitors for Pasithea Therapeutics.
Pasithea Therapeutics has a consensus price target of $2.00.
The stock price for Pasithea Therapeutics (NASDAQ: KTTA) is $2.24 last updated January 31, 2025 at 4:28 PM EST.
There are no upcoming dividends for Pasithea Therapeutics.
Pasithea Therapeutics’s Q4 earnings are confirmed for Friday, March 28, 2025.
There is no upcoming split for Pasithea Therapeutics.
Pasithea Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.